Mathias Müller

16PUBLICATIONS
108CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Innate immunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 03, 2025
Tyrosine kinase targeting uncovers oncogenic pathway plasticity in Tasmanian devil transmissible cancers.

Anna Schönbichler, Anna Orlova, Carmen Kreindl

|Sep 24, 2025
TYK2 Promotes Immunosurveillance of Colorectal Cancer Liver Metastasis.

Bernadette Mödl, Daniela Zwolanek, Katharina Schwertner

|Mar 02, 2025
Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions.

Anzhelika Karjalainen, Agnieszka Witalisz-Siepracka, Michaela Prchal-Murphy

|Dec 02, 2024
Lack of TYK2 signaling enhances host resistance to Candida albicans skin infection.

Sara Miranda, Caroline Lassnig, Kristina Schmidhofer

|Apr 24, 2024
JAK-STAT signaling maintains homeostasis in T cells and macrophages.

Nikolaus Fortelny, Matthias Farlik, Victoria Fife

|Apr 24, 2024
Dynamic control of gene expression by ISGF3 and IRF1 during IFNβ and IFNγ signaling.

Aarathy Ravi Sundar Jose Geetha, Katrin Fischer, Olga Babadei

Pageof 3

Frequent Collaborators

6 joint publications

Birgit Strobl

4 joint publications

Thomas Decker

3 joint publications

Caroline Lassnig

2 joint publications

Christoph Bock